Noqdirna is a new low-dose, orally disintegrating formulation of desmopressin that is indicated for the symptomatic treatment of nocturia due to idiopathic nocturnal polyuria in adults of all ages.
Mirabegron (Betmiga) is associated with a risk of severe hypertension, cerebrovascular and cardiac events, and is now contraindicated in patients with severe uncontrolled hypertension, the MHRA has advised.
Register or Subscribe to MIMSGPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.
MIMS bulletinsNews and updates straight to your inbox.
Prescribing Update: Fortnightly news bulletin
Alert: Urgent prescribing updates
Spotlight: Disease-themed monthly round-up
Read the latest issue online exclusively on MIMS Learning.
Especially created for prescribing influencers.